This paper provides an overview of the diagnosis and management of narcolepsy in early childhood. Focusing on the case literature for children aged eight years and under the paper reviews aspects of the pathophysiology, clinical symptomology and clinical management of the illness. In addition factors critical to the differential diagnosis of narcolepsy from a range of other pediatric illnesses are discussed. The literature examining the psychosocial implications of the disorder for children is also presented. Two major themes emerge from this review (i) the need for a reconceptualisation of the current diagnostic criteria for narcolepsy to allow for the observed heterogeneity and developmental variability of childhood onset narcolepsy, and, (ii) the need for increased attention to the psychosocial difficulties experienced by children in adjusting to this chronic illness. (J Pediatr Neurol 2004; 2(2): 65-71).
Introduction
Narcolepsy is a neurological disorder characterized by the dysregulation of the boundaries that control the separation of sleep from wakefulness. Whilst no prevalence estimates exist for young children adult rates suggest that narcolepsy has a prevalence of between 0.02 and 0.18% (1) . The primary symptom of narcolepsy is a pervasive and excessive daytime sleepiness that is overlaid by the intrusion of brief and irresistible nap episodes. Aspects of Rapid Eye Movement (REM) sleep, specifically the loss of voluntary muscle tone and the occurrence of dream episodes, also intrude into wakefulness as the auxiliary symptoms of cataplexy, sleep paralysis and hallucinations. Diagnosis of narcolepsy is currently based on both clinical presentation and/or polysomnographic criteria.
The literature has traditionally classified narcolepsy as a disorder of adulthood with childhood cases being described as atypical. However, several factors, including (i) a genetic component to the etiology of the illness (2), (ii) the retrospective reporting of many adult sufferers of childhood onset of symptoms (3) , and, (iii) a growing case study evidence base of childhood incidents of the disorder (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , would support the contention that the disorder should be more widely acknowledged as an illness of childhood and adolescence. More recent neurobiological research implicating the degeneration of orexin neurons in the pathogenesis of narcolepsy is also consistent with the potential for childhood illness onset. This paper will argue that current conceptualizations of, and diagnostic criteria for, narcolepsy often preclude the recognition of the disorder in childhood, particularly early childhood, and that the emerging case literature on childhood presentations of the illness argues for a reconceptualisation of these diagnostic criteria to recognize the potential heterogeneity and developmental variability of childhood symptoms of narcolepsy. Children eight years and under will be the primary focus of this paper, as this is both, (i) the approximate age of school transition, a developmental stage which often leads to the identification and investigation of abnormal sleepiness, and, (ii) the age at which children are likely to start presenting with adult polygraphic and clinical features of narcolepsy.
Pathophysiology
There is substantive support for a genetic component to narcolepsy with familial rates of occurrence being approximately 1:5 (14) . The genetic markers HLA-DR2 and DQB1*0602 have been associated with narcolepsy though genetic penetrance is low with only 0.2% of positive individuals developing narcolepsy (15) . Genetic factors are, therefore, not a sufficient condition for narcolepsy with twin studies suggesting a 25% concordance rate for the illness amongst monozygotic twins (1) . Proposed environmental triggers for narcolepsy have included changes to sleep wake schedules, psychological stressors, pregnancy and infectious diseases (16) .
More recently interest has focused on the role of the neuropeptide orexin (hypocretin) in the neurobiology of the disorder. A detailed review of this association is provided by Scammel (17) . Evidence from animal studies supports the role of orexin in both the promotion of wakefulness and the inhibition of REM sleep. Orexin knockout mice display a phenotype closely aligned with human narcolepsy with symptoms of excessive sleepiness, frequent REM transitions and cataplexy like behaviors (18) . The potential role of the attenuation of this neuropeptide in the pathophysiology of human narcolepsy is supported by the finding that seven out of nine human subjects presenting with narcolepsy demonstrated significant impairments in orexin signaling with an absence of the neuropeptide in cerebrospinal fluid (19) . The emergence of narcolepsy may then occur as a consequence of the gradual degeneration of orexin producing neurons in the hypothalamus. Factors that potentially mediate this degenerative process remain to be identified. More severe early onset incidences of narcolepsy may reflect either an accelerated degenerative process or be consequent to genetic mutations in genes coding for the neuropeptide or its receptor sites (17) . It remains for longitudinal research to identify potential associations between early onset narcolepsy and disorder severity and symptomology in adulthood.
Clinical presentation
Narcolepsy in adulthood is characterized by a tetrad of symptoms-(i) an excessive and pervasive daytime sleepiness (EDS) that is punctuated by the intrusion of brief and irresistible sleep attacks, (ii) cataplexy or the loss of voluntary muscle tone which occurs in response to emotionally arousing stimuli such as anger or laughter, (iii) hypnogogic or hypnopompic hallucinations, and, (iv) sleep paralysis. Individuals with narcolepsy demonstrate significant heterogeneity in relation to their clinical presentation. Although all subjects will present with excessive daytime sleepiness/sleep attacks only 70% will experience cataplexy and as few as 10% will present with the full tetrad of symptoms (20) . Narcolepsy is currently defined by the clinical presentation of sleep attacks coupled to either unequivocal cataplexy or the presence of pathological sleepiness and/or sleep onset REM (SOREM) periods measured using the Multiple Sleep Latency Test (MSLT) (21) . This paper will explore the clinical and polysomnographic presentation of children (aged under 8 at age of onset of symptoms) with narcolepsy to identify the complexities of locating this cohort within the current diagnostic framework. Reference will be made to both selected case study materials (4-13) Table 1 The critical features of this sleepiness include its persistence despite adequate nocturnal sleep and the inappropriateness of the sleep environments. Similar reports describe children sleeping while eating (8, 9, 11) , watching television (4, 8) , playing (9) , and even walking (11) . Sleepiness may not, however, be a predominant presenting symptom of childhood narcolepsy. In a review of 51 prepubertal children with narcolepsy of the five children aged under 5 years of age there were no reports of EDS (22) and it was only in response to questioning that patterns of difficulty with morning awakenings and the persistence of several daytime naps emerged. The definition of EDS in childhood is often difficult and subjective and this potentially becomes more confounded the younger the child. Napping behaviors may simply mask daytime sleepiness in the very young and it has been suggested that the persistence of daytime napping after about 4 years of age may be an early indicator of childhood EDS (23) . The transition to school, which precludes compensatory napping, often leads to the identification of this daytime sleepiness, as a 'problem behavior' (4, 6, 10) . In the previous review of prepubertal narcolepsy 78% of children over 5 presented with daytime sleepiness in response to school based concerns of abnormal sleepiness and associated attentional difficulties (22) .
Hypersomnolence in children may also present as hyperactivity (23, 24) and children may utilize increased activity as a strategy to mask or manage their excessive sleepiness (12) .
Sleep attacks or irresistible naps also appear to be characterized differently in childhood than adulthood. Adults with narcolepsy report these brief sleep episodes as refreshing yet reports of napping behaviors in children consistently describe children being difficult to arouse from naps and once awakened as experiencing residual irritability, confusion, restlessness, lethargy and disorientation (4, 8, 12) . Children with narcolepsy have been described as experiencing more chronic 'waxing and waning of drowsiness throughout the day' (p. S38, Ref. 24) than adults.
Cataplexy
Just as EDS demonstrates significant heterogeneity in childhood so too does the symptom of cataplexy. Classic symptoms of cataplexy, as described below, are only rarely reported.
The boy experienced sudden weakness when he laughed or became excited, often falling down; Clumsiness associated with falls or bumps, the unexplained dropping and breaking of objects or sudden changes in patterns of behavioral interactions have all been identified as key symptoms that may lead parents of pre school children to seek medical advice (22) . In infancy the presentation of cataplexy may only be evident following close behavioral observation and even then symptoms, if present, may be variously described as 'drop attacks' or 'funny turns' (5) and there may be no obvious association between these strange behaviors and the emotional triggers which define cataplexy. For many children presenting with EDS there is however no evidence of cataplexy (10) . This may reflect the inherent difficulties of (i) children reporting and describing the behavior (10), or, (ii) of adults observing and identifying the behavior (5). Alternatively cataplexy in children, may, as in adults, simply not emerge for some time subsequent to the development of EDS. Several case studies support this developmental sequence of symptomatology though it is suggested that the lag between EDS and auxiliary symptom onset may be less for children than adults. In a report of 77 cases of idiopathic childhood narcolepsy, cataplexy commenced on average within 1 year of EDS symptoms (3, 25) this contrasts with the reported lag of several years in adulthood (26) . This earlier onset profile for auxiliary symptoms of narcolepsy may support the proposition that the childhood presentation of narcolepsy represents a more severe variant of the adult disorder.
Hallucinations and sleep paralysis
Identification of cataplexy is, partially dependent, on the capacity of the child to report on their experience. This is especially true where there may be only mild symptoms that cannot be readily observed. This dependence on the child's reporting skills limits the capacity of very young children to name their experience as abnormal. A similar difficulty emerges with the identification of the auxiliary symptoms of sleep paralysis and hallucinations. Estimates suggest that 97% of children will experience EDS, 80% cataplexy, 39% hallucinations and 29% sleep paralysis with approximately 13% experiencing the full tetrad of symptoms (3). These estimates are similar to the distribution of symptoms reported for adults (20, 25) . It is important to note, however, that these estimates are based on a cohort of children with a mean age of onset of symptoms of 9 years and 9 months and therefore may not reflect the distribution within the younger cohort of particular relevance to this paper. It is clear that within increasing age of presentation both the clinical and polysomnographic symptom characteristics align with the adult presentation.
Differential diagnosis
The differential diagnosis of narcolepsy in early childhood involves an initial recognition that the child is having spontaneous unrefreshing sleep attacks that are not due to syncope or seizures. A history of episodes being preceded by an emotional upset or minor head trauma suggests non-epileptic vagal attacks (pallid apneic episodes) in which hypoxic seizures may not necessarily occur. These episodes of syncope are usually brief and the child recovers quickly (27) . Cardiogenic syncope is less common than the vaso-vagal forms, but the occurrence of episodes during exertion warrants further cardiac evaluation.
Hypersomnolence may be due to an unrefreshing nocturnal sleep pattern, i.e. nocturnal insomnia. This is most likely to be caused by obstructive sleep apnea, particularly in children with oro-cranial abnormalities such as large tonsils, retroposition of the mandible or a long soft palate (28) . Although a MSLT is technically problematic in diagnosing narcolepsy in young children (29) , a polygraphic nocturnal sleep recording can be performed to exclude obstructive sleep apnea and will also identify other causes of sleep apnea such as upper airway resistance syndrome and congenital central hypoventilation (30) . Obstructive sleep apnea with daytime somnolence has been described in a 3-year old girl with severe obesity i.e. the Pickwickian syndrome, which improved after weight reduction (31) . A type I Chiari malformation in a one year old girl caused central rather than obstructive sleep apnea, and this improved following decompression of the posterior fossa (32) . Periodic or recurrent hypersomnia which is not due to sleep apnea or narcolepsy is often due to hypothalmic dysfunction, e.g. from tumours, infarctions or arterio-venous malformations of the posterior hypothalamus (17) . A primary hypothalamic abnormality is also considered to be the cause of hypersomnia in the Prader-Willi syndrome, rather than the obesity that is a prominent feature of this condition (33) . Circadian rhythm disorders of childhood including advanced or delayed sleep phase syndrome may also require exclusion utilizing sleep-wake histories, sleep log data, actigraphy and polysomnography (34) .
Cataplexy is the other cardinal feature of narcolepsy which may be unrecognized initially, particularly if the history does not link excitement, laughter or other strong emotional response with the sudden loss of muscle tone. Myoclonic or atonic seizures may also be considered, but a prolonged electroencephalogram recording with concurrent video monitoring usually manages to capture an episode and provide the correct diagnosis. High serotonin levels have been suggested as the cause of cataplexy in Norrie disease, which is an Xlinked disorder associated with developmental delay, progressive deafness and ocular atrophy (35) . Coffin-Lowry syndrome is another X-linked condition in which cataplexy occurs. There is severe developmental delay, distinctive coarse facial features and tapering of the fingers (36) . Cataplexy has also been described as a clinical feature associated with tumours or inflammatory lesions of the ponto-medullary region (37) .
Niemann Pick disease type C presents a more difficult differential diagnosis from narcolepsy as both cataplexy and EDS can occur (3). There may be a history of persistent cholestatic jaundice in the neonatal period that improves after 2-3 months. This is followed by developmental delay, progressive ataxia, episodic dystonia and defective downgaze. In a review of 97 reported clinical cases of narcolepsy in children, Challamel (3) found 12 had Niemann Pick type C disease and suggested it should be considered when HLA typing for narcolepsy is negative. The diagnosis relies on demonstrating defective intracellular esterification of cholesterol in cultured skin fibroblasts (38) .
The presence of hypersomnolence and cataplexy is strongly suggestive of narcolepsy, particularly if the child has normal development and no dysmorphic features. Apart from testing for the HLA DR2 and DQB1*0602 markers, consideration can be given to performing an magnetic resonance image head scan, as well as obtaining a blood glucose and electrolytes and a urine drug screen. A polygraphic sleep recording, and prolonged electroencephalogram or electrocardiogram monitoring may be required when the clinical features are not conclusive. Although the genetic markers are not always present in idiopathic narcolepsy, their absence indicates a need for further investigations (17) .
Polysomnographic findings
A critical diagnostic tool in the identification of adult narcolepsy is the use of polysomnography particularly the MSLT. This test provides five discrete opportunities for subjects to sleep at 2-hour intervals over the day providing outcome measures of both sleep latency and latency to REM onset for each nap attempt. For adults a mean sleep latency of less than 5 minutes and/or the presence of 2 or more sleep onset REM periods is diagnostic of narcolepsy (21) . In young children, however, a range of maturational difficulties potentially confounds and invalidates the use of the MSLT. Children may have difficulty understanding the procedural requirements of the test and/or the test environment may create levels of anxiety in the child that significantly alters their sleep propensity and architecture (29 Where MSLT measures are undertaken in young children reports suggest that serial evaluations are often necessary for 'typical' features of the disorder to emerge (8, 23) . Criteria may also need to be adjusted with the suggestion that a mean sleep latency of less than 10 minutes be used as evidence of EDS in young children (23) . Despite the limitations of MSLT measures overnight polysomnographic recording is a useful tool in the evaluation of pediatric narcolepsy, providing both an opportunity to exclude nocturnal sleep disturbance as a causative factor for the presenting EDS and allowing the more general evaluation of the child's nocturnal sleep architecture.
Clinical management
This is a limited evidence base to evaluate the efficacy of the use of medications in the treatment of pediatric narcolepsy especially in the very young child. Findings suggest that young children are often not as responsive as older children while side effects may be more problematic (5) . Hypersomnolence is treated with medications that increase catecholamine levels either by increasing the release of dopamine, norepinephrine and serotonin, or by blocking their re-uptake (17) . In young children dextroamphetamine, methylphenidate, pemoline and mazindol have been used, but responses to even relatively high doses have been sub-optimal, and the need for daily naps is likely to persist (22) . Supplemental oxygen reduced the frequency and duration of somnolent episodes in an 18-month-old Childhood narcolepsy B M Hood and M G Harbord boy reported by the authors (5), even though there were no episodes of apnea. Tyrosine at a dose of 100 mg/kg/day successfully improved wakefulness in a 2-year-old boy, but this was replaced by methylphenidate at age 6 years due to increasing episodes of cataplexy (9) . If cataplexy does not respond to stimulant medication then tricyclics (clomipramine) at a dose of 1 mg/kg is often used, and may also help other REM based symptoms such as nightmares, sleep terrors and sleep paralysis (22) . For preschool children, where sleepiness is often not labeled as a problem behavior, a daytime nap schedule may be the most appropriate treatment strategy. With the commencement of school however, nap schedules may need to be augmented with stimulant medication to ensure that the child's EDS does not limit their opportunities to be involved both academically and socially with their school aged peers. Following diagnosis all children and families require education about narcolepsy and longitudinal psychosocial support to facilitate adjustment to the disorder.
Psychosocial issues
The experience of adults with narcolepsy is generally one of significant psychosocial impairment across interpersonal, vocational, educational and familial life areas (39) . Over 50% of adult sufferers have been reported as experiencing depression with almost 25% reporting recurrent suicidal ideation (40) . What remains unclear is the extent to which these outcomes are a reactive response to the difficulties that this adult cohort of sufferers have experienced of achieving both diagnosis and acceptance for the illness. The literature pertaining to children continues however to parallel these adult findings. Difficulties of diagnosis have resulted in the attribution of symptoms to a range of alternate diagnoses including epilepsy, attention deficit disorder, conversion disorder, willful behavioral difficulties and schizophrenia (22) . The authors of the current paper have described a case where symptoms of narcolepsy in a preschool child were attributed to Munchausen syndrome by proxy. This diagnosis led to the child's treatment being managed primarily by the state protection services and the focus of treatment shifting from the child to the family members (5) . Even following diagnosis children with narcolepsy generally continue to struggle with psychosocial difficulties including emotional lability, aggressive behaviors, social isolation, bullying, academic underachievement and depression (10, 22, 24) . These difficulties may emerge in part from the lack of acceptance these children experience for the 'reality of the illness'. Excessive daytime sleepiness is often attributed to negative traits such as laziness, diminished intellectual ability, or a lack of motivation and these children may continue to be labeled in this way despite diagnosis (24) . Children report significant levels of stigma associated with the illness. Ninety percent (of a cohort of 40 children aged 7 years and older) described a sense of shame with the illness and wanted to hide it from their school peers while 20% were assessed as having symptoms of reactive depression (22) . Whilst EDS may be unremarkable and unproblematic for the preschool child it is clear that the experience of school transition is a critical period of adjustment that requires appropriate management of the clinical and emotional needs of the child. No published longitudinal research exists to evaluate the impact of early clinical and psychosocial interventions on these adjustment issues nor does a literature base exist evaluating the relative efficacy of alternate psychosocial intervention strategies in facilitating the psychological well-being of these children. It is evident that narcolepsy in the young child must not just be treated as a clinical disorder but must be recognized as a potentially disabling chronic illness with the need to address both clinical and psychosocial components of the illness experience.
